JZL184
CAS No. 1101854-58-3
JZL184 ( JZL184; JZL 184; JZL-184 )
Catalog No. M17810 CAS No. 1101854-58-3
JZL 184 is a potent and selective inhibitor of MAGL with IC50 of 8 nM and 4 μM for inhibition of MAGL and FAAH in mouse brain membranes respectively.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 31 | In Stock |
|
10MG | 49 | In Stock |
|
25MG | 104 | In Stock |
|
50MG | 197 | In Stock |
|
100MG | 357 | In Stock |
|
200MG | 482 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameJZL184
-
NoteResearch use only, not for human use.
-
Brief DescriptionJZL 184 is a potent and selective inhibitor of MAGL with IC50 of 8 nM and 4 μM for inhibition of MAGL and FAAH in mouse brain membranes respectively.
-
DescriptionJZL184 is highly selective, and potent MAGL inhibitor ( monoacylglycerol lipase inhibitor). JZL184 improves behavior and neural properties in Ts65Dn mice, a model of down syndrome. JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action. JZL184 also suppresses inflammatory pain in the mouse carrageenan model.
-
SynonymsJZL184; JZL 184; JZL-184
-
PathwayOthers
-
TargetOther Targets
-
RecptorMAGL
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number1101854-58-3
-
Formula Weight520.49
-
Molecular FormulaC27H24N2O9
-
Purity98%
-
SolubilityDMSO : ≥ 35 mg/mL; 67.24 mM
-
SMILESOC(C1CCN(CC1)C(=O)Oc1ccc(cc1)[N+](=O)[O-])(c1ccc2OCOc2c1)c1ccc2OCOc2c1
-
Chemical Name4-nitrophenyl 4-(bis(benzo[d][1,3]dioxol-5-yl)(hydroxy)methyl)piperidine-1-carboxylate.
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Long JZ, et al. Nat Chem Biol, 2009, 5(1), 37-44.
molnova catalog
related products
-
EGFRvIII peptide PEP...
PEPvIII, a peptide sequence from EGFRvIII, was designed to represent a target of glioma and is presented by MHC I/II complexes.
-
VPC-18005
VPC-18005 is a luciferase inhibitor. VPC-18005 inhibits ERG-induced transcription and interacts directly with the ERG-ETS domain thereby disrupting the ERG binding to DNA.
-
WAY-604116
WAY-604116 has anti-inflammatory, antitumor and antiasthmatic effects.